+321.3%
WMB vs MRNA
+840.0%
-518.7%
-66.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | -3.9% | +3.7% | -0.2% |
| 7D | 0.0% | -17.6% | +17.6% | -0.1% |
| 30D | -5.4% | -5.1% | -0.2% | -5.4% |
| 3M | -7.5% | +220.8% | -228.3% | -6.8% |
| 6M | -11.9% | +321.7% | -333.6% | -11.4% |
| YTD | +14.7% | +601.3% | -586.6% | +14.8% |
| 1Y | +16.0% | +735.2% | -719.2% | +15.9% |
| 3Y | +113.0% | +170.5% | -57.5% | +113.5% |
| 5Y | +197.9% | -14.6% | +212.5% | +197.3% |
| All | +321.3% | +840.0% | -518.7% | +354.1% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling